About
Company Strategy
Group Structure
Board of directors
Management
Career
Contacts
Development
Drugs
Medical devices
Medical services
Biotech valuation
Activity
Areas of activities
Research and development (R&D) stages
Ecosystem
Acceleration
Commercialization
Investor
Disclosure of information
News
En
RU
CN
Главная
News
News
News, press releases, events, publications
Press releases
All categories
Portfolio
Portfolio
Nextgen
Gemabank
Biotechnology Developments
Genetico
Betuvax
Histograft
Genotarget
20.03.2024
Press releases
Artgen Biotech will not conduct SPO
12.02.2024
Press releases
RBT conducted preclinical studies of a new immunomodulating drug
01.02.2024
Press releases
ALOR BROKER published an analytical report on Gemabank
01.02.2024
Press releases
The Ministry of Health issued permission to Artgen Biotech to conduct clinical trials of an innovative drug for the treatment of cystitis
22.01.2024
Press releases
Artgen Biotech updated its development strategy
18.01.2024
Press releases
Results of Artgen Biotech activities for 9 months of 2023
15.01.2024
Press releases
Histograft will conduct clinical trials of gene-activated material for the treatment of the spine
1
…
7
8
9
10
11
…
14
Up
About the Company
About
Company Strategy
Group Structure
Board of Directors
Management
Career
Contacts
Development Portfolio
Drugs
Medical Devices
Medical Services
Activity
Areas of activities
Research and development (R&D) stages
Ecosystem
Acceleration
Commercialization
Biotech Valuation
Investors
Disclosure of information
